Inventor · disambiguated record
Geoffrey Phillip Symonds
Also filed as: SYMONDS GEOFFREY · SYMONDS GEOFFREY P · SYMONDS GEOFFREY PHILLIP
15 granted patents·15 pending applications·194 citations·filing 1994–2023
92Inventor score
Files withCSL BEHRING GENE THERAPY INC8CALIMMUNE INC4JOHNSON & JOHNSON RES PTY LTD3MALLINCKRODT HOSPITAL PRODUCTS IP LTD3SYMONDS GEOFFREY P3
Top patents by PatentIndex Score
30 records- 0192US10926020B2Processing bloodMALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2018·Granted Feb 23, 2021·3 cites·20 claims
- 0292US7345025B2Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cellsJOHNSON & JOHNSON RES PTY LTD·Filed 2002·Granted Mar 18, 2008·58 cites·18 claims
- 0385US5712384ARibozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructsGENE SHEARS PTY LTD·Filed 1994·Granted Jan 27, 1998·85 cites·8 claims
- 0482US10961537B2Compositions and methods for treating beta-hemoglobinopathiesCSL BEHRING GENE THERAPY INC·Filed 2018·Granted Mar 30, 2021·2 cites·27 claims
- 0582US10953149B2Processing bloodMALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2018·Granted Mar 23, 2021·2 cites·24 claims
- 0682US10940259B2Processing bloodMALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2018·Granted Mar 9, 2021·2 cites·24 claims
- 0776US2024043845A1Compositions and methods for treating beta-hemoglobinopathiesCSL BEHRING GENE THERAPY INC·Filed 2023·Application pending·0 cites
- 0873US6114167ARibozymes targeting the MoMLV PSI packaging sequence and the HIV tat sequenceGENE SHEARS PTY LTD·Filed 1994·Granted Sep 5, 2000·37 cites·12 claims
- 0971US12447253B2Processing bloodTHERAKOS DEVELOPMENT LTD·Filed 2021·Granted Oct 21, 2025·0 cites·20 claims
- 1069US11795461B2Compositions and methods for treating beta-hemoglobinopathiesCSL BEHRING GENE THERAPY INC·Filed 2021·Granted Oct 24, 2023·0 cites·21 claims
- 1169US10426798B2Modulatable switch for selection of donor modified cellsCALIMMUNE INC·Filed 2018·Granted Oct 1, 2019·1 cites·17 claims
- 1269US7994144B2Process for the preparation of a composition of genetically modified hematopoietic progenitor cellsJOHNSON & JOHNSON RES PTY LTD·Filed 2002·Granted Aug 9, 2011·3 cites·29 claims
- 1369US7776595B2Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cellsJOHNSON & JOHNSON RES PTY LTD·Filed 2006·Granted Aug 17, 2010·1 cites·12 claims
- 1468US11213548B2Modulatable switch for selection of donor modified cellsCSL BEHRING GENE THERAPY INC·Filed 2019·Granted Jan 4, 2022·0 cites·25 claims
- 1566US2010210989A1Processing bloodMACPHERSON JANET LESLEY·Filed 2009·Application pending·0 cites
- 1666US2022016176A1Dual vector for inhibition of human immunodeficiency virusCSL BEHRING GENE THERAPY INC·Filed 2021·Application pending·0 cites
- 1764US2022072046A1Modulatable switch for selection of donor modified cellsCSL BEHRING GENE THERAPY INC·Filed 2021·Application pending·0 cites
- 1861US2021032627A1Gene therapeutic for the treatment of hiv and uses thereofCSL BEHRING GENE THERAPY INC·Filed 2020·Application pending·0 cites
- 1958US2013344040A1Process for the preparation of a composition of genetically modified hematopoietic progenitor cellsSYMONDS GEOFFREY P·Filed 2013·Application pending·0 cites
- 2055US11008630B2Methods for discriminating between HIV-1 and lentiviral vectorsCSL BEHRING GENE THERAPY INC·Filed 2019·Granted May 18, 2021·0 cites·9 claims
- 2153US2012058092A1Process for the preparation of a composition of genetically modified hematopoietic progenitor cellsSYMONDS GEOFFREY P·Filed 2011·Application pending·0 cites
- 2251US2018112220A1Gene therapeutic for the treatment of hiv and uses thereofCALIMMUNE INC·Filed 2017·Application pending·0 cites
- 2348US10240214B2Methods for discriminating between HIV-1 and lentiviral vectorsCALIMMUNE INC·Filed 2017·Granted Mar 26, 2019·0 cites·10 claims
- 2447US2021340563A1Donor t-cells with kill switchCSL BEHRING LLC·Filed 2021·Application pending·0 cites
- 2544US2016243169A1Dual vector for inhibition of human immunodeficiency virusCALIMMUNE INC·Filed 2016·Application pending·0 cites
- 2643US2012201794A1Dual vector for inhibition of human immunodeficiency virusCHEN IRVIN·Filed 2010·Application pending·0 cites
- 2738US2006051866A1Means of producing and utilising a population of disease specific cytotoxic t-lymphocytesSYMONDS GEOFFREY P·Filed 2003·Application pending·0 cites
- 2837US2003082158A1Production of transduced hematopoietic progenitor cellsFiled 2002·Application pending·0 cites
- 2937US2002160393A1Double-stranded RNA-mediated gene suppressionFiled 2001·Application pending·0 cites
- 3027US2002058636A1Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructsFiled 1995·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Geoffrey Phillip Symonds files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →